We are live on ! Find out more

QTI

QT Imaging Holdings

QTI

Market cap $37.8M

2.58 USD

+0.02

0.78%

At close Updated Sep 16, 4:00 PM EDT

Pre-market

After hours

2.64

+0.06

2.33%

1 day

0.78%

5 days

-5.49%

1 month

-4.44%

3 months

-34.52%

6 months

-61.61%

Year to date

-56.93%

1 year

-56.93%

5 years

-73.89%

10 years

-73.89%

About: QT Imaging Holdings Inc. is a medical device company engaged in the research, development, and commercialization of body imaging systems using low frequency sound waves. Its medical imaging is critical to the detection, diagnosis, and treatment of disease. The company offers two products: QT Breast Scanner and QTviewer.

Employees: 32

Healthcare Medical Devices

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 0%

Neutral 100%

Negative 0%

QT Imaging Holdings, Inc. (QTI) Presents at IAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 Transcript

QT Imaging Holdings, Inc. (QTI) Presents at IAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 Transcript

QT Imaging Holdings, Inc. (QTI) Presents at IAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 Transcript

QT Imaging to Participate in the iAccess Alpha Virtual Best Ideas Fall Investment Conference

NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced its participation in the iAccess Alpha Virtual Best Ideas Fall Investment Conference 2026, taking place September 15–16, 2026. Chief Financial Officer Jay Jennings will deliver a company presentation at 3:30 pm ET on September 15, followed by one.

QT Imaging to Participate in the iAccess Alpha Virtual Best Ideas Fall Investment Conference

QT Imaging Issues Mid-Year 2026 CEO Letter to Shareholders

NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today issued a mid-year 2026 letter to shareholders from its CEO, Dr. Raluca Dinu. The full text of the letter appears below and at this link which can be found on the QT Imaging website. Dear Fellow Shareholders, I am energized by QT Imaging's many accomplishme.

QT Imaging Issues Mid-Year 2026 CEO Letter to Shareholders

QT Imaging Holdings, Inc. (QTI) Q2 2026 Earnings Call Transcript

QT Imaging Holdings, Inc. (QTI) Q2 2026 Earnings Call Transcript

QT Imaging Holdings, Inc. (QTI) Q2 2026 Earnings Call Transcript

QT Imaging Delivers Strong Second Quarter Growth While Building the Foundation for Commercial Scale

NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holding, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today reported financial results for the three and six months ended June 30, 2026, and provided a business update. “Our second quarter results demonstrate continued execution and the growing commercial momentum of QT Imaging. Revenue more than doubled year-over-y.

QT Imaging Delivers Strong Second Quarter Growth While Building the Foundation for Commercial Scale

QT Imaging to Report Second Quarter 2026 Financial Results and Host Conference Call on August 12, 2026

NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that it will report financial results for the second quarter ended June 30, 2026, after market close on Wednesday, August 12, 2026, and will host a conference call beginning at 4:30 p.m. Eastern Time. Participants are encouraged to pre-register a.

QT Imaging to Report Second Quarter 2026 Financial Results and Host Conference Call on August 12, 2026

QT Imaging Advances Direct U.S. Commercial Strategy to Accelerate Adoption of its Breast Acoustic CT Scanner with Two Key Hires

NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today advanced the direct U.S. commercial strategy for its Breast Acoustic CT™ Scanner with the appointment of Jason Dyer as Vice President Regional Sales East and Dave Reinhart as Vice President Regional Sales West. Both executives joined QT Imaging in July 202.

QT Imaging Advances Direct U.S. Commercial Strategy to Accelerate Adoption of its Breast Acoustic CT Scanner with Two Key Hires

QT Imaging Appoints Medical Imaging and Digital Health Executive Dr. Julia Albright as Chief Science Officer

NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced the appointment of Julia Albright, Ph.D., as Chief Science Officer (“CSO”), effective July 27, 2026. Dr. Albright brings more than 25 years of experience spanning medical imaging, digital health, oncology, cloud technologies, and the development.

QT Imaging Appoints Medical Imaging and Digital Health Executive Dr. Julia Albright as Chief Science Officer

QT Imaging Holdings Announces Results of 2026 Annual Stockholder Meeting

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (“QT Imaging” or the “Company”) (NASDAQ: QTI), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, announced today that at the Annual Meeting of Company's stockholders (the “Annual Meeting”) held on July 28, 2026, the Company's stockholders voted to approve (i) the election of Professor Zeev Weiner and Bryan Timm as Class II directors to serve until the Compan.

QT Imaging Holdings Announces Results of 2026 Annual Stockholder Meeting

QT Imaging Receives Israeli Ministry of Health Regulatory Registration

NOVATO, Calif.--(BUSINESS WIRE)---- $QTI #BreastCancer--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that the Israeli Ministry of Health has granted registration for the Company's scanner, authorizing commercialization of the system in Israel through February 2, 2028. The approval is based on the Company's existing U.S. FDA clearance and applica.

QT Imaging Receives Israeli Ministry of Health Regulatory Registration

See News Rankings

Price charts implemented using Lightweight Charts™